pozen inc (POZN:NASDAQ GS)
Executive Profile*
John R. Plachetka Pharm D.Co-Founder, Chairman of the Board, Chief Executive Officer and President, POZEN Inc. |
| Age | Total Calculated Compensation | This person is connected to 12 board members in 1 different organizations across 1 different industries. See Board Relationships |
| 58 | $2,854,283 As of Fiscal Year 2012 |
Background*
Dr. John R. Plachetka, Pharm D. is a co-founder of Pozen Inc. and has been its President and Chief Executive Officer since 1996. Mr. Plachetka served as Vice President of Development at Texas Biotechnology Corporation from 1993 to 1995. Prior to founding POZEN, Dr. Plachetka was Vice President of Development at Texas Biotechnology Corporation from 1993 to 1995 and served as the President and Chief Executive Officer of Clinical Research Foundation-America, a leading ...
Corporate Headquarters*1414 Raleigh RoadChapel Hill, North Carolina 27517 United States Phone: 919-913-1030 Fax: 919-913-1039 Board Members Memberships*1996-Present Co-Founder, Chairman of the Board, Chief Executive Officer and President
Education*Doctorate University of Missouri, Kansas City BS University of Illinois at Chicago College of Pharmacy
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| POZN:US | $4.96 USD | +0.06 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Daniel N. Swisher Jr. | Chief Executive Officer, President and Director Sunesis Pharmaceuticals, Inc. | $431.9K |
| Remi Barbier | Founder, Chairman, Chief Executive Officer and President Pain Therapeutics Inc. | $1.2M |
| Robert W. Cook | Interim Chief Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance & Administration, Secretary and Director EpiCept Corporation | $326.2K |
| Mark A. Sirgo Pharm.D. | Chief Executive Officer, President, Chief Scientific Officer, Executive Director, Member of Executive Subcommittee and Member of Risk Management Committee BioDelivery Sciences International, Inc. | $620.5K |
| Timothy P. Walbert | Chairman, Chief Executive Officer, President, Chief Executive Officer of Horizon Pharma USA, President of Horizon Pharma USA and Director of Horizon Pharma USA Horizon Pharma, Inc. | $572.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact POZEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
